Friday, July 31, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Neutral Normal choppiness · VIX 17.4
The market is sharply bifurcated: a severe semiconductor and AI-capex-linked selloff (AMD, Micron, Intel, Applied Materials, Lam Research, KLA, Marvell, Sandisk, Corning all down 15-46% over the past month) is dragging down tech sentiment, while financials, insurers, exchanges, healthcare diagnostics, and energy refiners are showing sustained, broad-based strength and trading near their 52-week highs. This dispersion suggests rotation out of high-multiple AI hardware plays into steadier earners rather than a broad risk-off move.
DexCom makes continuous glucose monitors used by people with diabetes to track their blood sugar. The stock has surged over 22% in a month, is still climbing week over week, and is beating the overall market by a wide margin, with technical readings showing healthy (not overheated) strength. The main risk is that after such a fast run-up, any pause in buying could trigger a pullback, and several company insiders have been selling shares.
Why the AI likes it
What could go wrong
Calibrated probability: 74% (raw model estimate: 68%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
IQVIA runs clinical trials and provides data and analytics services for pharmaceutical and healthcare companies. It just reported a much stronger quarter than expected and raised its full-year profit outlook, and the stock is still trading below its recent peak. The main risk is that the stock already jumped sharply in the days right after the earnings news, so some of the good news may already be reflected in the price.
Why the AI likes it
What could go wrong
Calibrated probability: 75% (raw model estimate: 70%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Nucor is the largest steel producer in the U.S. It just posted record quarterly earnings and management expects results to be even better next quarter, thanks to strong demand from infrastructure and industrial investment. The main risks are that several company executives have been selling stock recently, and steel demand can slow if the broader economy weakens.
Why the AI likes it
What could go wrong
Calibrated probability: 75% (raw model estimate: 70%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Willis Towers Watson is an insurance brokerage and consulting firm. Recent results beat expectations, and notably, the CEO and another top executive personally bought company stock in the past few months, a sign of insider confidence. The main risk is that the stock has already risen sharply and technical indicators suggest it may be a bit overbought in the short term.
Why the AI likes it
What could go wrong
Calibrated probability: 75% (raw model estimate: 72%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
MetLife is one of the largest life-insurance and employee-benefits companies, a classic steady-earner type of business that's currently in favor with investors. The stock is near its one-month high with consistent upward momentum. The main risk is that MetLife reports earnings in about a week, which falls inside our 30-day window and could cause a sharp move in either direction.
Why the AI likes it
What could go wrong
Calibrated probability: 74% (raw model estimate: 62%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by August 30, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 503 S&P 500 constituents and short-listed 28 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.